Skip to main content
OpenTrials
Completed

NCT Number: NCT01197729

OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry

OPTAMI documents the characteristics of consecutive patients with acute STEMI and NSTEMI in hospital everyday-life in Germany, their acute and adjuvant medication treatment, events until discharge (e.g. mortality, stroke, re-MI), and their medication for secondary prevention at discharge.

In the follow up-period of one year, information is collected concerning events as mortality, stroke, re-MI, coronary interventions (PCI, CABG) and re-hospitalisation.

The implementation of guideline-adjusted therapy in hospital everyday-life is reviewed. The usefulness of the European standard for data acquisition in cardiology (CARDS = Cardiology Audit and Registration Standards) is evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myocardial Infarction Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Ischemia Necrosis Non-ST Elevated Myocardial Infarction Non-ST-Elevation Myocardial Infarction Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction ST-elevation Myocardial Infarction Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Medizinische Klinik und Poliklinik, Universitätklinikum Münster, Münster, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients admitted to hospital with an acute ST-Elevation myocardial infarction or with an acute Non-ST-Elevation myocardial infarction, both not older than 24 h

Exclusion criteria

  • missing informed consent

Treatment and study plan

Primary outcomes

  1. Documentation of characteristics from consecutive patients with an acute STEMI or an acute NSTEMI in hospital daily routine in Germany.

    Time frame: 10/01/2005-02/01/2009

Secondary outcomes

  1. Documentation of acute invasive and adjuvant medical therapy of STEMI and NSTEMI in hospital daily routine in Germany

    Time frame: 10/01/2005-02/01/2009

  2. Documentation of hospital mortality and non-fatal cerebrovascular complications (stroke, re-myocardial infarction)

    Time frame: 10/01/2005-02/01/2009

  3. Documentation of medication for secondary prevention at hospital discharge

    Time frame: 10/01/2005-02/01/2009

  4. Documentation of the one-year mortality, the non-fatal cerebrovascular complications (stroke, re-myocardial infarction) as well as of the coronar interventions (PCI, Bypass operation) and hospital admissions during the first year post STEMI or NSTEMI

    Time frame: 10/01/2005-02/01/2009

  5. Verification of the benefits of the European Standards for Data Collection for Cardiology (CARDS = Cardiology Audit and Register Standards) in daily hospital routine.

    Time frame: 10/01/2005-02/01/2009

  6. Verification of the implementation of therapy according to the guidelines for STEMI and NSTEMI patients in daily hospital routine in Germany.

    Time frame: 10/01/2005-02/01/2009

Sponsors and collaborators

Lead sponsor

Stiftung Institut fuer Herzinfarktforschung

Other

Collaborators

  • GlaxoSmithKline
  • Klinikum Nürnberg
  • University Hospital Muenster

Registry information

Official study title

OPTAMI (Optimierte Therapie Des Akuten Myokard-Infarktes) - Register

Acronym: OPTAMI

Important dates

Study start
2005
Primary completion
2009
Study completion
2010
First posted
Sep 9, 2010
Registry last updated
Dec 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.